ShockWave Medical, Inc.
SWAV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $11,950,198 | $7,037,391 | $7,326,297 | $10,464,080 |
| - Cash | $281,674 | $328,422 | $498,108 | $141,458 |
| + Debt | $776,799 | $770,607 | $764,853 | $59,053 |
| Enterprise Value | $12,445,323 | $7,479,576 | $7,593,042 | $10,381,675 |
| Revenue | $218,805 | $202,979 | $186,020 | $180,165 |
| % Growth | 7.8% | 9.1% | 3.2% | – |
| Gross Profit | $190,598 | $177,663 | $161,507 | $155,672 |
| % Margin | 87.1% | 87.5% | 86.8% | 86.4% |
| EBITDA | $56,051 | $61,485 | $50,598 | $36,380 |
| % Margin | 25.6% | 30.3% | 27.2% | 20.2% |
| Net Income | $55,346 | $44,305 | $34,986 | $28,862 |
| % Margin | 25.3% | 21.8% | 18.8% | 16% |
| EPS Diluted | 1.44 | 1.16 | 0.92 | 0.76 |
| % Growth | 24.1% | 26.1% | 21.1% | – |
| Operating Cash Flow | $35,840 | $71,703 | $50,651 | $39,737 |
| Capital Expenditures | -$8,389 | -$8,121 | -$6,538 | -$8,748 |
| Free Cash Flow | $27,451 | $63,582 | $44,113 | $30,989 |